Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Palumbo

Showing results (411-420 of 497) with videos related to

Pageof 50
Sort By:
Leukemia|February 6, 2014
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaM A Dimopoulos, X Leleu, A Palumbo, et al.
Leukemia|September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working GroupE Terpos, M A Dimopoulos, O Sezer, et al.
Aging|December 14, 2021
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosisLucia Longhitano, Daniele Tibullo, Nunzio Vicario, et al.
Leukemia|May 28, 2025
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyureaFrancesca Palandri, Massimo Breccia, Elena M Elli, et al.
Experimental Hematology|November 12, 2013
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemiaRossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, et al.
Antioxidants (Basel, Switzerland)|April 27, 2024
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis PatientsRenata Mangione, Cesarina Giallongo, Andrea Duminuco, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Multiple Myeloma in 2023 Ways: From Trials to Real LifeManlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
Leukemia|December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myelomaS Bringhen, M D'Agostino, L De Paoli, et al.
Leukemia Research|November 19, 2013
Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter studyJudith Neukirchen, Michael Lauseker, Sabine Blum, et al.
Pageof 50

Showing results (411-420 of 497) with videos related to

Sort By:
Pageof 50
Leukemia|February 6, 2014
Expert panel consensus statement on the optimal use of pomalidomide in relapsed and refractory multiple myelomaM A Dimopoulos, X Leleu, A Palumbo, et al.
Leukemia|September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working GroupE Terpos, M A Dimopoulos, O Sezer, et al.
Aging|December 14, 2021
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosisLucia Longhitano, Daniele Tibullo, Nunzio Vicario, et al.
Leukemia|May 28, 2025
Impact of ELN clinical signs and symptoms on the thrombotic risk in polycythemia vera patients treated with front-line hydroxyureaFrancesca Palandri, Massimo Breccia, Elena M Elli, et al.
Experimental Hematology|November 12, 2013
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemiaRossana Maffei, Stefania Fiorcari, Jenny Bulgarelli, et al.
Antioxidants (Basel, Switzerland)|April 27, 2024
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis PatientsRenata Mangione, Cesarina Giallongo, Andrea Duminuco, et al.
Current Oncology (Toronto, Ont.)|November 24, 2023
Multiple Myeloma in 2023 Ways: From Trials to Real LifeManlio Fazio, Vittorio Del Fabro, Nunziatina Laura Parrinello, et al.
Haematologica|January 18, 2015
The genotype of MLH1 identifies a subgroup of follicular lymphoma patients who do not benefit from doxorubicin: FIL-FOLL studyDavide Rossi, Alessio Bruscaggin, Piera La Cava, et al.
Leukemia|December 22, 2017
Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myelomaS Bringhen, M D'Agostino, L De Paoli, et al.
Leukemia Research|November 19, 2013
Validation of the revised international prognostic scoring system (IPSS-R) in patients with myelodysplastic syndrome: a multicenter studyJudith Neukirchen, Michael Lauseker, Sabine Blum, et al.
Pageof 50